A first-in-human phase i study of MORAb-004, a monoclonal antibody to endosialin in patients with advanced solid tumors.
Clinical Cancer Research.
Times cited: 21
The future of epigenetic therapy in solid tumours - Lessons from the past.
Nature Reviews Clinical Oncology.
Times cited: 150